CHEMOMAB THERAPEUTICS LTD
CMMB·16385C203·US·ADR·Healthcare - Biotechnology-Activist
CMMB (CHEMOMAB THERAPEUTICS LTD) is held by 7 institutional investors as of Q1 2026. Largest holders: CITADEL ADVISORS LLC ($100,766), XTX Topco Ltd ($29,248), RHUMBLINE ADVISERS ($28,832). Net institutional sentiment: Mixed.
7
Holders
Avg rating(1 Elite)
$200,450
Total Value
40% (10)
Fund Consensus
4 buying - 6 selling
Who's Trading
InsiderMAMor George AdiBuy $10KMay 29, 2026
InsiderMAMor George AdiBuy $10KMay 29, 2026
ActivistPTPeter Thiel4.6%Feb 17, 2026
ActivistOEOtto Erik6.3%Feb 10, 2026
ActivistOIORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP4.8%Jun 23, 2025
ActivistSPSphera Funds Management Ltd.4.8%Apr 10, 2025
13F: Insider & Congress:
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer